NIOX Group PLC (NIOX) - Total Assets
Based on the latest financial reports, NIOX Group PLC (NIOX) holds total assets worth GBX76.20 Million GBX (≈ $9.27K USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check cash flow reinvestment rate of NIOX Group PLC to assess the company's total reinvestment commitment from operating cash flow.
NIOX Group PLC - Total Assets Trend (2013–2025)
This chart illustrates how NIOX Group PLC's total assets have evolved over time, based on quarterly financial data. Check how high is NIOX Group PLC's earnings quality to evaluate the quality of earnings relative to operating cash generation.
NIOX Group PLC - Asset Composition Analysis
Current Asset Composition (December 2025)
NIOX Group PLC's total assets of GBX76.20 Million consist of 40.6% current assets and 59.5% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 26.1% |
| Accounts Receivable | GBX6.00 Million | 7.9% |
| Inventory | GBX5.00 Million | 6.6% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX23.80 Million | 31.2% |
| Goodwill | GBX4.80 Million | 6.3% |
Asset Composition Trend (2013–2025)
This chart illustrates how NIOX Group PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see NIOX stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: NIOX Group PLC's current assets represent 40.6% of total assets in 2025, a decrease from 94.2% in 2013.
- Cash Position: Cash and equivalents constituted 26.1% of total assets in 2025, down from 62.0% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 37.0% of total assets, an increase from 4.0% in 2013.
- Asset Diversification: The largest asset category is intangible assets at 31.2% of total assets.
NIOX Group PLC Competitors by Total Assets
Key competitors of NIOX Group PLC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Inspire Medical Systems Inc
NYSE:INSP
|
USA | $911.38 Million |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $90.55 Million |
|
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186
|
China | CN¥1.59 Billion |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
|
China | CN¥805.10 Million |
|
Stratec SE
XETRA:SBS
|
Germany | €443.38 Million |
|
Scandinavian Medical Solutions AS
CO:SMSMED
|
Denmark | Dkr205.86 Million |
|
Duearity AB
ST:DEAR
|
Sweden | Skr10.84 Million |
NIOX Group PLC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.81 | 2.60 | 1.83 |
| Quick Ratio | 3.20 | 2.11 | 1.58 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX22.80 Million | GBX13.00 Million | GBX9.00 Million |
NIOX Group PLC - Advanced Valuation Insights
This section examines the relationship between NIOX Group PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.77 |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | 11.4% |
| Total Assets | GBX76.20 Million |
| Market Capitalization | $2.95 Million USD |
Valuation Analysis
Below Book Valuation: The market values NIOX Group PLC's assets below their book value (0.04x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: NIOX Group PLC's assets grew by 11.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for NIOX Group PLC (2013–2025)
The table below shows the annual total assets of NIOX Group PLC from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | GBX76.20 Million ≈ $9.27K |
+11.40% |
| 2024-12-31 | GBX68.40 Million ≈ $8.32K |
-25.25% |
| 2023-12-31 | GBX91.50 Million ≈ $11.13K |
0.00% |
| 2023-12-30 | GBX91.50 Million ≈ $11.13K |
-7.11% |
| 2022-12-31 | GBX98.50 Million ≈ $11.98K |
0.00% |
| 2022-12-30 | GBX98.50 Million ≈ $11.98K |
+14.00% |
| 2021-12-31 | GBX86.40 Million ≈ $10.51K |
0.00% |
| 2021-12-30 | GBX86.40 Million ≈ $10.51K |
-16.20% |
| 2020-12-31 | GBX103.10 Million ≈ $12.54K |
0.00% |
| 2020-12-30 | GBX103.10 Million ≈ $12.54K |
-58.23% |
| 2019-12-31 | GBX246.80 Million ≈ $30.03K |
0.00% |
| 2019-12-30 | GBX246.80 Million ≈ $30.03K |
-19.71% |
| 2018-12-31 | GBX307.40 Million ≈ $37.40K |
0.00% |
| 2018-12-30 | GBX307.40 Million ≈ $37.40K |
-23.61% |
| 2017-12-31 | GBX402.40 Million ≈ $48.96K |
0.00% |
| 2017-12-30 | GBX402.40 Million ≈ $48.96K |
+20.44% |
| 2016-12-31 | GBX334.10 Million ≈ $40.65K |
0.00% |
| 2016-12-30 | GBX334.10 Million ≈ $40.65K |
-31.70% |
| 2015-12-31 | GBX489.20 Million ≈ $59.52K |
0.00% |
| 2015-12-30 | GBX489.20 Million ≈ $59.52K |
+143.99% |
| 2014-12-31 | GBX200.50 Million ≈ $24.40K |
0.00% |
| 2014-12-30 | GBX200.50 Million ≈ $24.40K |
+427.19% |
| 2013-12-31 | GBX38.03 Million ≈ $4.63K |
0.00% |
| 2013-12-30 | GBX38.03 Million ≈ $4.63K |
-- |
About NIOX Group PLC
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual disposable mouthpieces, and breathing handles for the measurement of fractional exhaled nitric oxide … Read more